CBN, New Delhi Busted Illicit Drug Syndicate, Seized Large Quantity Of NDPS Drugs Worth More Than A Crore

New Delhi: In continuous crackdown on illicit drug menace, Central bureau of Narcotics, New Delhi achieved a major breakthrough and busted the clandestine illicit drug syndicate operating at M/s V K Enterprises at New Shobatia Bag Area in Prayagraj and arrested the proprietor Vipul Tiwari s/o Vinod Tiwari of the firm.

The firm was a distributor of various NDPS medicines which are meant to be disbursed under strict medical supervision. Central Bureau of Narcotics seized the following NDPS drugs:

Ketamine- 6273 Vial, Tramadol Tab- 4530 Tab, Tramadol Cap.- 113616 Cap, Tramadol Inj. – 12150 Inj Alprazolam Tab. – 136200, Diazepam Tabs- 8600, Diazepam Inj. – 1200, Clonazepam Tab.- 8500, Chlordiazepoxide Tab.- 300, Lorazepam Inj.- 3910, Nitrazepam Tab. – 4100, Codeine Phosphate tab- 150, Codeine Phosphate Syrup- 890, Etizolam Tab. 200, Clobazam Tab.- 3200, Pentazocine Inj.- 26890, Buprenorphine Inj.- 1225, Buprenorphine Patch- 12, Fentanyl Patch- 309, Fentanyl vial/inj- 2817, Medicinal Opium Pills- 220 Grams, Midazolam Vial – 325, Morphine Sulphate Inj. – 140, Morphine Sulphate Tab.- 660.

The firm was consciously indulged in diversion of NDPS medicines into the illicit drug market.

It is pertinent to mention that Fentanyl is one of the most potent medicines which is used for acute pain management and this medicine may cause casualty if it is not taken under strict medical supervision.

A case crime no. 01/24 has been registered and further investigation in the case is under progress.

Related Posts

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

Milan: CPHI Milan 2026, one of the pharmaceutical industry’s largest global events, has launched four specialist zones designed to connect pharmaceutical companies with the technologies, services and expertise shaping the…

Lilly takes 6 companies to court for selling retatrutide knockoffs

Washington: Eli Lilly’s experimental weight-loss drug retatrutide has yet to be approved by the FDA. But the buzz surrounding the effectiveness of the compound—commonly known as triple-G—has already triggered a…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

Lilly takes 6 companies to court for selling retatrutide knockoffs

Lilly takes 6 companies to court for selling retatrutide knockoffs

FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch